期刊文献+

早期慢性肾脏病左心室肥厚与血胱抑素C相关性分析 被引量:3

Research on correlations of serum cystatin C with left ventricular hypertrophy in early stage of chronic kidney disease
下载PDF
导出
摘要 目的探讨早期肾脏病血胱抑素C与左心室肥厚(LVH)的相关性。方法入选诊断符合K-DOQI定义的CKD 1~3期标准住院患者50例,同时检测血肌酐、血胱抑素C等生化指标,超声心动图测量计算左心室质量指数(LVMI)。结果本组患者LVH的发生率为54.0%,其中DOQI-1为21.4%,DOQI-2为62.5%,DOQI-3为70.0%。随着肾小球滤过率(eGFR)下降,LVH发生率逐渐上升。血肌酐、收缩压、平均动脉压、CRP、血糖、总胆固醇,血胱抑素C与LVH正相关,eGFR、Hb、LVEF与LVH呈负相关。多元回归分析显示胱抑素C水平与LVMI呈独立的显著正相关(β=0.525,P=0.010)。结论早期慢性肾脏病患者血胱抑素C浓度与LVH呈显著正相关;血胱抑素C可以作为早期慢性肾脏病患者LVH的血清学预测指标。 Objective To study the relation of cystatin C and LVH in the early stage of CKD .Method Fifty hospitalized patients were enrolled in the study according to the definition of DOQI 1~3 Standard.Serum cystatin C,serum creatinine and other biochemical mak-ers were measured , left ventricular internal diameter ( LVIDd ) , left ventricular posterior wall thickness ( LVPWTd ) , interventricular septal thickness(IVSTd) in diastole were measured by echocardiography .V mass was calculated and left ventricular hypertrophy was assessed .Re-sults The prevalence of LVH in our patients was 54.0%,21.4%in stage 1 CKD,62.5%in stage 2 and 70%in stage 3.Increasing preva-lence of LVH accompanied with declining renal function .Serum creatinine,systolic blood pressure,mean arterial blood pressure,CRP,blood glucose,total cholesterol,serum cystatin C was positively correlated with LVH ,while eGFR,Hb,LVEF was negatively correlated with LVH .Af-ter multiple linear regression,serum cystatin C remained independently and significantly associated with LVH (β=0.525,P=0.010).Con-clusions Serum cystatin C is positively corelated with LVH independently and significantly in the early stage of CKD ( DOQI 1~3 );serum cystatin C is a serological predictor of LVH in the early stage of CKD .
出处 《安徽医学》 2014年第9期1219-1222,共4页 Anhui Medical Journal
关键词 慢性肾脏病 血胱抑素C 肾小球滤过率 左心室肥厚 Chronic kidney disease Serum cystatin C eGFR Left ventricular hypertrophy
  • 相关文献

参考文献7

  • 1Emilio Nardi,Alessandro Palermo,Giuseppe Mulè,Paola Cusimano,Santina Cottone,Giovanni Cerasola.Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease[J].Journal of Hypertension.2009(3)
  • 2Joachim H. Ix,Michael G. Shlipak,Glenn M. Chertow,Sadia Ali,Nelson B. Schiller,Mary A. Whooley.Cystatin C, Left Ventricular Hypertrophy, and Diastolic Dysfunction: Data From the Heart and Soul Study[J].Journal of Cardiac Failure.2006(8)
  • 3Ernesto Paoletti,Diego Bellino,Paolo Cassottana,Davide Rolla,Giuseppe Cannella.Left Ventricular Hypertrophy in Nondiabetic Predialysis CKD[J].American Journal of Kidney Diseases.2005(2)
  • 4邓庆梅,李飞,刘秀霞.血清胱抑素C评价肾小球滤过率的临床意义[J].安徽医学,2013,34(3):325-327. 被引量:23
  • 5Adeera Levin,Joel Singer,Christopher R. Thompson,Heather Ross,Mary Lewis.Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention[J].American Journal of Kidney Diseases.1996(3)
  • 6Mark J Sarnak.Cardiovascular complications in chronic kidney disease[J].American Journal of Kidney Diseases.2003
  • 7王冰,郭兴来,高勇.血清胱抑素C尿β_2微球蛋白和尿微量白蛋白联合检测在恶性肿瘤患者早期肾功能损害中的应用[J].安徽医学,2013,34(12):1840-1843. 被引量:11

二级参考文献21

共引文献32

同被引文献35

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 2胡锦睿,徐永远,应丽红,曹豪杰.慢性肾衰竭患者早期心脏结构及功能的初步观察[J].现代中西医结合杂志,2007,16(27):3937-3939. 被引量:3
  • 3Collins AJ,Foley RN, Chavers B,et al. United States RenalData System 2011 Annual Data Report: Atlas of chronic kid-ney disease&^end-stage renal disease in the United States[J].Am J Kidney Dis, 2012,59(1 Suppl 1): A7, el-420.
  • 4Foley RN,Gilbertson DT,Murray T,et al. Long interdialyticinterval and mortality among patients receiving hemodialysis[J]. N Engl J Med, 2011, 365(12): 1099-1107.
  • 5Dialysis and Transplantation Registration Group. The reportabout the registration of dialysis and transplantation in China1999[J]. Chin J Nephrol, 2001, 17(2): 77-78.
  • 6Cai QZ, Lu XZ, Lu Y,et al. Longitudinal Changes of CardiacStructure and Function in CKD (CASCADE Study) [J].JASN, 2014,25(7): 1599-1608.
  • 7London GM, Pannier B,Guerin AP, et al. Alterations of leftventricular hypertrophy in and survival of patients receivinghemodialysis: follow-up of an interventional study[J]. J AmSoc Nephrol, 2001,12(12): 2759-2767.
  • 8Kessler M, Zannad F,Lehert P, et al. Predictors of cardio-vascular events in patients with end-stage renal disease : an a-nalysis from the fosinopril in dialysis study [J]. Nephrol IXalTransplant, 2007,22(12): 3573-3579.
  • 9Kidney Disease Improving Global Outcomes, KDIGO 2012Clinical Practice Guideline for the Evaluation and Managementof Chronic Kidney Disease [J]. Kidney International Supple-ments 3,2013,3(1): 19-62.
  • 10Levey AS, Stevens LA, Schmid CH, et al. A new equation toestimate glomerularfiltration rate[J]. Ann Intern Med, 2009,150(9): 604-612.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部